GAS6 and COVID-19: In COVID-19 and non-COVID-19 ICU patients, the GAS6 concentration at study inclusion was 24.2 (16.8–31.9) ng/mL and 12.1 (9.5–15.9) ng/mL respectively, indicating a significant difference between both groups (p < 0.001; Fig. 2A).